| BP0083-50MG
| InVivoPlus mouse IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0290-50MG
| InVivoPlus rat IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BP0307-5MG
| InVivoPlus anti-mouse CD16/CD32
| 5 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0012-5MG
| InVivoPlus anti-mouse CD25 (IL-2R?)
| 5 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-5MG
| InVivoPlus recombinant CTLA-4-Ig (hum./hum.)
| 5 mg
| BioXCell
|
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| SIM0014-1MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 1 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| CP151-100MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0061-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0297-50MG
| InVivoPlus human IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| BP0057-5MG
| InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-?
| 5 mg
| BioXCell
| in vivo TGF? neutralization, in vitro TGF? neutral
|
| Mouse
| mouse/human/rat/monkey/hamster/canine/bovin
| Solicitar Precio
| Solicitar
|
| BP0036-50MG
| InVivoPlus anti-mouse NK1.1
| 50 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0004-1-50MG
| InVivoPlus anti-mouse CD8?
| 50 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0003-25MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 25 mg
| BioXCell
| Blocking of PD-1/PD-L signaling; Flow Cytometry; I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0307-50MG
| InVivoPlus anti-mouse CD16/CD32
| 50 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0087-100MG
| InVivoPlus polyclonal Syrian hamster IgG
| 100 mg
| BioXCell
|
|
| Syrian hamster
| N/
| Solicitar Precio
| Solicitar
|
| SIM0010-50MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 50 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0085-25MG
| InVivoPlus mouse IgG2a isotype control
| 25 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0090-25MG
| InVivoPlus rat IgG2b I sotype control
| 25 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BP0241-25MG
| InVivoPlus anti-mouse IFNAR-1
| 25 mg
| BioXCell
| in vivo IFNAR-1 blockade, in vitro IFNAR-1 blockad
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0075-1-100MG
| InVivoPlus anti-mouse Ly6G
| 100 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0268-1MG
| ReadyTag anti-HA
| 1 mg
| BioXCell
| ELISA, Western blot, Immunoprecipitation, Immunofl
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0033-2-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0045-5MG
| InVivoPlus anti-mouse IL-4
| 5 mg
| BioXCell
| in vitro IL-4 neutralization, in vivo IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0090-5MG
| InVivoPlus rat IgG2b I sotype control
| 5 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BP0003-3-5MG
| InVivoPlus anti-mouse CD4
| 5 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| CP151-5MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0008-50MG
| InVivoSIM anti-human CD20 (Rituximab Biosimilar)
| 50 mg
| BioXCell
| Flow Cytometry; ELISA; Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0006-50MG
| InVivoSIM anti-human TNF? (Infliximab Biosimilar)
| 50 mg
| BioXCell
| TNF? neutralization; Flow Cytometry; ELISA; Wester
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0310-5MG
| InVivoPlus anti-mouse VISTA
| 5 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0004-1-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0213-25MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 25 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF-R1 neut
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0356-25MG
| InVivoPlus anti-mouse CD20
| 25 mg
| BioXCell
| in vivo B cell depletion, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0045-25MG
| InVivoPlus anti-mouse IL-4
| 25 mg
| BioXCell
| in vitro IL-4 neutralization, in vivo IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| CP148-50MG
| RecombiMAb human IgG4 S228P L235E P329G (SPLEPG) isotype control, anti-hen egg lysozyme
| 50 mg
| BioXCell
|
|
| Human
| Othe
| Solicitar Precio
| Solicitar
|
| BP0057-50MG
| InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-?
| 50 mg
| BioXCell
| in vivo TGF? neutralization, in vitro TGF? neutral
|
| Mouse
| mouse/human/rat/monkey/hamster/canine/bovin
| Solicitar Precio
| Solicitar
|
| BP0131-50MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 50 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| CP147-100MG
| RecombiMAb human IgG4 (S228P) isotype control, anti-hen egg lysozyme
| 100 mg
| BioXCell
|
|
| Human
| Othe
| Solicitar Precio
| Solicitar
|
| SIM0007-1MG
| InVivoSIM anti-human VEGF (Bevacizumab Biosimilar)
| 1 mg
| BioXCell
| VEGF neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0001-100MG
| InVivoSIM anti-human TNF? (Adalimumab Biosimilar)
| 100 mg
| BioXCell
| TNF? neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0079-25MG
| InVivoPlus anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 25 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BP0131-5MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0083-5MG
| InVivoPlus mouse IgG1 isotype control
| 5 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0115-100MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 100 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0087-50MG
| InVivoPlus polyclonal Syrian hamster IgG
| 50 mg
| BioXCell
|
|
| Syrian hamster
| N/
| Solicitar Precio
| Solicitar
|
| BP0173-100MG
| InVivoPlus anti-mouse IL-17A
| 100 mg
| BioXCell
| in vivo IL-17A neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0005-5MG
| InVivoSIM anti-human HER2 (Trastuzumab Biosimilar)
| 5 mg
| BioXCell
| Flow Cytometry; ELISA; Immunohistochemistry; Weste
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0241-50MG
| InVivoPlus anti-mouse IFNAR-1
| 50 mg
| BioXCell
| in vivo IFNAR-1 blockade, in vitro IFNAR-1 blockad
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0091-5MG
| InVivoPlus polyclonal Armenian hamster IgG
| 5 mg
| BioXCell
|
|
| Armenian hamster
| N/
| Solicitar Precio
| Solicitar
|
| BP0117-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0308-100MG
| InVivoPlus anti-rat CD4
| 100 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|